PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-04-29

Date Title Company
29-Apr-2021 Moderna Announces Additional Investments to Increase Global Supply for COVID-19 Vaccine to up to 3 Billion Doses in 2022 Moderna
29-Apr-2021 HUTCHMED Initiates Phase II Registration Study of HMPL 689 in Patients with Follicular Lymphoma and Marginal Zone Lymphoma in China HUTCHMED
29-Apr-2021 GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen’s Award for Enterprise in Innovation GW Pharmaceuticals
29-Apr-2021 Bone Therapeutics announces 2020 full year results Bone Therapeutics
29-Apr-2021 Verona Pharma Reports First Quarter 2021 Financial Results and Provides Corporate Update Verona Pharma
29-Apr-2021 Results from large-scale real-world safety study for oral combination contraception pill, Zoely® (NOMAC-E2), submitted to European Medicines Agency Theramex
29-Apr-2021 Bachem celebrates the hire of its 1000th employee at the Bubendorf site Bachem
29-Apr-2021 Biosample Hub – a new ethical and transparent way of connecting Biobanks and Biotechs Biosample Hub
29-Apr-2021 Viscosupplementation Market Size 2021 Industry Demand, Share, Future Trends Plans, Growth Opportunities, Key Players, Application, Demand, Industry Research Report by COVID-19 Impact Analysis 2027 CDN Newswire
29-Apr-2021 Asklepios Group: 2020 financial year dominated by COVID-19 pandemic and Rhön acquisition Asklepios Kliniken
29-Apr-2021 Chiesi teams up with Innovate UK award winning SMEs to improve sustainability of respiratory inhaler devices Chiesi Limited
29-Apr-2021 Advanced Biological Laboratories Receives CE-IVD Registration for its UltraGene SARS-CoV-2 Triplex Assay Advanced Biological Laboratories (ABL)
29-Apr-2021 Santhera and ReveraGen Announce New 2.5-year Treatment Data with Vamorolone in Duchenne Muscular Dystrophy Santhera
29-Apr-2021 Guy's and St Thomas' NHS Foundation Trust Selects Nuance Dragon Medical One As Part of a Large-Scale Digital Transformation Nuance Communications, Inc.
29-Apr-2021 Vertex Announces European Commission Approval for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With Ivacaftor to Treat Cystic Fibrosis Patients 12 Years and Older With At Least One F508del Mutation in the CFTR gene Vertex
29-Apr-2021 ProductLife Group Enters US Market with Acquisition of Leading Regulatory Drug Development Consultancy DS InPharmatics (DSI) ProductLife Group (PLG)
29-Apr-2021 Panthera becomes the world’s first clinical trial site to administer Valneva’s inactivated COVID-19 vaccine (VLA2001) to volunteers in phase 3 study Panthera
29-Apr-2021 Cambridge Research Biochemicals signs distribution deal with Fluoroprobes, LLC Cambridge Research Biochemicals
29-Apr-2021 APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share APONTIS PHARMA AG
29-Apr-2021 Cambridge Research Biochemicals signs distribution deal with Fluoroprobes, LLC Sciad Newswire